n-methylaspartate has been researched along with trans-sodium crocetinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Nakanishi, T; Ohno, Y; Shimazawa, M; Tsuruma, K; Umigai, N | 1 |
| Chen, YY; Li, HP; Li, Q; Qu, LJ; Xue, Y; Yin, JT; Zhao, XF | 1 |
2 other study(ies) available for n-methylaspartate and trans-sodium crocetinate
| Article | Year |
|---|---|
Oral administration of crocetin prevents inner retinal damage induced by N-methyl-D-aspartate in mice.
Topics: Administration, Oral; Animals; Apoptosis; Calpain; Carotenoids; Caspase 3; Cell Count; Cytoprotection; Enzyme Induction; Male; Mice; N-Methylaspartate; Retina; Retinal Ganglion Cells; Vitamin A | 2012 |
N-methyl-D-aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products.
Topics: Alzheimer Disease; Biological Products; Humans; Ligands; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 2023 |